Processa Pharmaceuticals to Present at “Zooming with LD Micro” Virtual Investor Event on July 29, 2021 at 12:00 p.m. ET
27 Luglio 2021 - 2:30PM
Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) announced today that
it will be presenting at the upcoming “Zooming with LD Micro”
virtual investor event on Thursday, July 29th, 2021 at 12:00 PM ET.
Investors and other individuals may access the
virtual presentation by registering here:
https://us02web.zoom.us/webinar/register/WN_NUnXZfaETuihigrh1PspxA
About Processa Pharmaceuticals,
Inc.
The mission of Processa has been to develop
products where existing clinical evidence of efficacy already
exists in unmet medical need conditions, medical conditions where
patients need treatment options that will improve survival and/or
quality of life. The Company has assembled a proven regulatory
science development team, management team, and Board of Directors.
The Processa development team has been involved with more than 30
drug approvals by the FDA (including drug products targeted to
orphan disease conditions) and 100 FDA meetings. For more
information, please
visit http://www.processapharma.com.
For More Information:Michael
Floydmfloyd@processapharma.com(301) 651-4256
James CarbonaraHayden IR(646)
755-7412james@haydenir.com
Grafico Azioni Processa Pharmaceuticals (NASDAQ:PCSA)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Processa Pharmaceuticals (NASDAQ:PCSA)
Storico
Da Lug 2023 a Lug 2024